The coronary ligament continues as the right triangular ligament.

Structure and Relations of the Liver

The liver is divided into four lobes: the right lobe, left lobe, quadrate lobe, and caudate lobe. The right lobe is supplied by the right hepatic artery and contains Couinaud segments V to VIII, while the left lobe is supplied by the left hepatic artery and contains Couinaud segments II to IV. The quadrate lobe is part of the right lobe anatomically but functionally is part of the left, and the caudate lobe is supplied by both right and left hepatic arteries and lies behind the plane of the porta hepatis. The liver lobules are separated by portal canals that contain the portal triad: the hepatic artery, portal vein, and tributary of bile duct.

The liver has various relations with other organs in the body. Anteriorly, it is related to the diaphragm, esophagus, xiphoid process, stomach, duodenum, hepatic flexure of colon, right kidney, gallbladder, and inferior vena cava. The porta hepatis is located on the postero-inferior surface of the liver and transmits the common hepatic duct, hepatic artery, portal vein, sympathetic and parasympathetic nerve fibers, and lymphatic drainage of the liver and nodes.

The liver is supported by ligaments, including the falciform ligament, which is a two-layer fold of peritoneum from the umbilicus to the anterior liver surface and contains the ligamentum teres (remnant of the umbilical vein). The ligamentum venosum is a remnant of the ductus venosus. The liver is supplied by the hepatic artery and drained by the hepatic veins and portal vein. Its nervous supply comes from the sympathetic and parasympathetic trunks of the coeliac plexus.

Pseudomembranous colitis is caused by the gram-positive bacillus Clostridium difficile, which can overgrow in the intestine following broad-spectrum antibiotic use. A patient recovering from a total hip replacement who develops signs of infection and is treated with clindamycin may develop severe abdominal pain and diarrhea, indicating a diagnosis of pseudomembranous colitis. Treatment options include metronidazole or oral vancomycin for more severe cases. Staphylococcus bacteria are gram-positive, catalase-positive cocci that can be differentiated based on coagulase positivity and novobiocin sensitivity. Listeria, Bacillus, and Corynebacterium are gram-positive aerobic bacilli, while Campylobacter jejuni, Vibrio cholerae, and Helicobacter pylori are gram-negative, oxidase-positive comma-shaped rods with specific growth characteristics.

Clostridium difficile is a type of bacteria that is commonly found in hospitals. It produces a toxin that can damage the intestines and cause a condition called pseudomembranous colitis. This bacteria usually develops when the normal gut flora is disrupted by broad-spectrum antibiotics, with second and third generation cephalosporins being the leading cause. Other risk factors include the use of proton pump inhibitors. Symptoms of C. difficile infection include diarrhea, abdominal pain, and a raised white blood cell count. The severity of the infection can be determined using the Public Health England severity scale.

To diagnose C. difficile infection, a stool sample is tested for the presence of the C. difficile toxin. Treatment involves reviewing current antibiotic therapy and stopping antibiotics if possible. For a first episode of infection, oral vancomycin is the first-line therapy for 10 days, followed by oral fidaxomicin as second-line therapy and oral vancomycin with or without IV metronidazole as third-line therapy. Recurrent infections may require different treatment options, such as oral fidaxomicin within 12 weeks of symptom resolution or oral vancomycin or fidaxomicin after 12 weeks of symptom resolution. In life-threatening cases, oral vancomycin and IV metronidazole may be used, and surgery may be considered with specialist advice. Other therapies, such as bezlotoxumab and fecal microbiota transplant, may also be considered for preventing recurrences in certain cases.

A fistula is a connection that is not normal between two surfaces that are lined with epithelial cells. In the case of a fistula in ano, it will be lined with squamous cells.

Fistulas are abnormal connections between two epithelial surfaces, with various types ranging from those in the neck to those in the abdomen. The majority of fistulas in surgical practice arise from diverticular disease and Crohn’s. In general, all fistulas will heal spontaneously as long as there is no distal obstruction. However, this is particularly true for intestinal fistulas. There are four types of fistulas: enterocutaneous, enteroenteric or enterocolic, enterovaginal, and enterovesicular. Management of fistulas involves protecting the skin, managing high output fistulas with octreotide, and addressing nutritional complications. When managing perianal fistulas, it is important to avoid probing the fistula in cases of acute inflammation and to use setons for drainage in cases of Crohn’s disease. It is also important to delineate the fistula anatomy using imaging studies.

The correct answer is Secretin. S cells in the upper small intestine secrete this gastrointestinal hormone, which promotes the secretion of bicarbonate-rich fluid from the pancreas. Pancreatic secretinomas, a rare type of gastrointestinal neuroendocrine tumor, can cause watery diarrhea.

Cholecystokinin is another gastrointestinal hormone that promotes the contraction of the gallbladder and the secretion of bile at the ampulla of Vater. However, it does not promote the secretion of bicarbonate-rich fluid from the pancreas.

Gastrin is a gastrointestinal hormone that promotes gastric motility and the secretion of hydrochloric acid by parietal cells. It is released by the G cells of the gastric antrum.

Motilin is a gastrointestinal hormone secreted by M cells within Peyer’s patches of the small intestine, which promotes gastrointestinal motility.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

Acute pancreatitis can be caused by mumps virus.

The symptoms described in the scenario are consistent with acute pancreatitis. The mnemonic ‘I GET SMASHED’ is a helpful tool for identifying risk factors for this condition, and mumps virus is included in this list.

While hepatitis B and C viruses have been associated with cases of pancreatitis, they are not known to directly cause the condition. influenzae virus is also not a known cause of acute pancreatitis.

However, mumps virus is a known cause of acute pancreatitis. In addition to symptoms of pancreatitis, patients may also experience other symptoms of mumps virus. The severity of the pancreatitis is typically mild in these cases.

Acute pancreatitis is a condition that is primarily caused by gallstones and alcohol consumption in the UK. However, there are other factors that can contribute to the development of this condition. A popular mnemonic used to remember these factors is GET SMASHED, which stands for gallstones, ethanol, trauma, steroids, mumps, autoimmune diseases, scorpion venom, hypertriglyceridaemia, hyperchylomicronaemia, hypercalcaemia, hypothermia, ERCP, and certain drugs. It is important to note that pancreatitis is seven times more common in patients taking mesalazine than sulfasalazine. CT scans can show diffuse parenchymal enlargement with oedema and indistinct margins in patients with acute pancreatitis.

The presence of goblet cells is a requirement for the diagnosis of Barrett’s esophagus.

Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, which increases the risk of oesophageal adenocarcinoma by 50-100 fold. It is usually identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia, as there are no screening programs for it. The length of the affected segment determines the chances of identifying metaplasia, with short (<3 cm) and long (>3 cm) subtypes. The prevalence of Barrett’s oesophagus is estimated to be around 1 in 20, and it is identified in up to 12% of those undergoing endoscopy for reflux.

The columnar epithelium in Barrett’s oesophagus may resemble that of the cardiac region of the stomach or that of the small intestine, with goblet cells and brush border. The single strongest risk factor for Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD), followed by male gender, smoking, and central obesity. Alcohol is not an independent risk factor for Barrett’s, but it is associated with both GORD and oesophageal cancer. Patients with Barrett’s oesophagus often have coexistent GORD symptoms.

The management of Barrett’s oesophagus involves high-dose proton pump inhibitor, although the evidence base for its effectiveness in reducing the progression to dysplasia or inducing regression of the lesion is limited. Endoscopic surveillance with biopsies is recommended every 3-5 years for patients with metaplasia but not dysplasia. If dysplasia of any grade is identified, endoscopic intervention is offered, such as radiofrequency ablation, which is the preferred first-line treatment, particularly for low-grade dysplasia, or endoscopic mucosal resection.

Acute upper gastrointestinal bleeding is a common and significant medical issue that can be caused by various conditions, with oesophageal varices and peptic ulcer disease being the most common. The main symptoms include haematemesis (vomiting of blood), melena (passage of altered blood per rectum), and a raised urea level due to the protein meal of the blood. The diagnosis can be determined by identifying the specific features associated with a particular condition, such as stigmata of chronic liver disease for oesophageal varices or abdominal pain for peptic ulcer disease.

The differential diagnosis for acute upper gastrointestinal bleeding includes oesophageal, gastric, and duodenal causes. Oesophageal varices may present with a large volume of fresh blood, while gastric ulcers may cause low volume bleeds that present as iron deficiency anaemia. Duodenal ulcers are usually posteriorly sited and may erode the gastroduodenal artery. Aorto-enteric fistula is a rare but important cause of major haemorrhage associated with high mortality in patients with previous abdominal aortic aneurysm surgery.

The management of acute upper gastrointestinal bleeding involves risk assessment using the Glasgow-Blatchford score, which helps clinicians decide whether patients can be managed as outpatients or not. Resuscitation involves ABC, wide-bore intravenous access, and platelet transfusion if actively bleeding platelet count is less than 50 x 10*9/litre. Endoscopy should be offered immediately after resuscitation in patients with a severe bleed, and all patients should have endoscopy within 24 hours. Treatment options include repeat endoscopy, interventional radiology, and surgery for non-variceal bleeding, while terlipressin and prophylactic antibiotics should be given to patients with variceal bleeding. Band ligation should be used for oesophageal varices, and injections of N-butyl-2-cyanoacrylate for patients with gastric varices. Transjugular intrahepatic portosystemic shunts (TIPS) should be offered if bleeding from varices is not controlled with the above measures.

The HLA most commonly associated with coeliac disease is HLA-DQ2. HLA, also known as human leukocyte antigen or major histocompatibility complex, is expressed on self-cells in the body and plays a role in presenting antigens to the immune system. The child’s symptoms of coeliac disease include fatty, floaty stools (steatorrhoea), weight loss, and positive tissue transglutaminase antibodies.

HLA-A01 is not commonly associated with autoimmune conditions, but has been linked to methotrexate-induced liver cirrhosis.

HLA-B27 is associated with psoriatic arthritis, reactive arthritis, ankylosing spondylitis, and inflammatory bowel disease.

HLA-B35 is not commonly associated with autoimmune conditions.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

Typically, the pH level in the stomach is 2, but the use of proton pump inhibitors can effectively eliminate acidity.

Understanding Gastric Secretions for Surgical Procedures

A basic understanding of gastric secretions is crucial for surgeons, especially when dealing with patients who have undergone acid-lowering procedures or are prescribed anti-secretory drugs. Gastric acid, produced by the parietal cells in the stomach, has a pH of around 2 and is maintained by the H+/K+ ATPase pump. Sodium and chloride ions are actively secreted from the parietal cell into the canaliculus, creating a negative potential across the membrane. Carbonic anhydrase forms carbonic acid, which dissociates, and the hydrogen ions formed by dissociation leave the cell via the H+/K+ antiporter pump. This leaves hydrogen and chloride ions in the canaliculus, which mix and are secreted into the lumen of the oxyntic gland.

There are three phases of gastric secretion: the cephalic phase, gastric phase, and intestinal phase. The cephalic phase is stimulated by the smell or taste of food and causes 30% of acid production. The gastric phase, which is caused by stomach distension, low H+, or peptides, causes 60% of acid production. The intestinal phase, which is caused by high acidity, distension, or hypertonic solutions in the duodenum, inhibits gastric acid secretion via enterogastrones and neural reflexes.

The regulation of gastric acid production involves various factors that increase or decrease production. Factors that increase production include vagal nerve stimulation, gastrin release, and histamine release. Factors that decrease production include somatostatin, cholecystokinin, and secretin. Understanding these factors and their associated pharmacology is essential for surgeons.

In summary, a working knowledge of gastric secretions is crucial for surgical procedures, especially when dealing with patients who have undergone acid-lowering procedures or are prescribed anti-secretory drugs. Understanding the phases of gastric secretion and the regulation of gastric acid production is essential for successful surgical outcomes.

The irreversible blockade of H+/K+ ATPase is caused by PPIs.

Parietal cells contain H+/K+-ATPase, which is inhibited by omeprazole, a proton pump inhibitor. Therefore, any answer indicating chief cells or H+/K+-ATPase stimulation is incorrect and potentially harmful.

Ranitidine is an example of a different class of gastroprotective drugs that inhibits H2 receptors.

Understanding Proton Pump Inhibitors

Proton pump inhibitors (PPIs) are medications that work by blocking the H+/K+ ATPase in the stomach’s parietal cells. This action is irreversible and helps to reduce the amount of acid produced in the stomach. Examples of PPIs include omeprazole and lansoprazole.

Despite their effectiveness in treating conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers, PPIs can have adverse effects. These include hyponatremia and hypomagnesemia, which are low levels of sodium and magnesium in the blood, respectively. Prolonged use of PPIs can also increase the risk of osteoporosis, leading to an increased risk of fractures. Additionally, there is a potential for microscopic colitis and an increased risk of C. difficile infections.

It is important to weigh the benefits and risks of PPIs with your healthcare provider and to use them only as directed. Regular monitoring of electrolyte levels and bone density may also be necessary for those on long-term PPI therapy.

The patient’s symptoms suggest pancreatic insufficiency, possibly due to chronic pancreatitis and alcohol misuse, as evidenced by weight loss and steatorrhea. To test pancreatic function, secretin stimulation test can be used as it increases the secretion of bicarbonate-rich fluid from pancreas and hepatic duct cells. Gastrin, on the other hand, increases HCL production, while incretin stimulates insulin secretion after food intake. Although insulin and glucagon are pancreatic hormones, they are not primarily involved in the secretion of bicarbonate-rich fluid from pancreas and hepatic duct cells, but rather in regulating glucose levels.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

Hereditary haemochromatosis is a genetic disorder that affects how the body processes iron. It is inherited in an autosomal recessive pattern. The symptoms in the early stages can be vague and non-specific, such as feeling tired and experiencing joint pain. As the condition progresses, it can lead to chronic liver disease and a condition known as bronze diabetes, which is characterized by iron buildup in the pancreas causing diabetes, and a bronze or grey pigmentation of the skin. Based on the patient’s symptoms of joint pain, elevated ALT levels, and significantly high ferritin levels, it is highly likely that they have haemochromatosis.

Understanding Haemochromatosis: Symptoms and Complications

Haemochromatosis is a genetic disorder that affects iron absorption and metabolism, leading to iron accumulation in the body. It is caused by mutations in the HFE gene on both copies of chromosome 6. This disorder is prevalent in people of European descent, with 1 in 10 carrying a mutation in the genes affecting iron metabolism. Early symptoms of haemochromatosis are often non-specific, such as lethargy and arthralgia, and may go unnoticed. However, as the disease progresses, patients may experience fatigue, erectile dysfunction, and skin pigmentation.

Other complications of haemochromatosis include diabetes mellitus, liver disease, cardiac failure, hypogonadism, and arthritis. While some symptoms are reversible with treatment, such as cardiomyopathy, skin pigmentation, diabetes mellitus, hypogonadotrophic hypogonadism, and arthropathy, liver cirrhosis is irreversible.

Acute pancreatitis is a condition that is primarily caused by gallstones and alcohol consumption in the UK. However, there are other factors that can contribute to the development of this condition. A popular mnemonic used to remember these factors is GET SMASHED, which stands for gallstones, ethanol, trauma, steroids, mumps, autoimmune diseases, scorpion venom, hypertriglyceridaemia, hyperchylomicronaemia, hypercalcaemia, hypothermia, ERCP, and certain drugs. It is important to note that pancreatitis is seven times more common in patients taking mesalazine than sulfasalazine. CT scans can show diffuse parenchymal enlargement with oedema and indistinct margins in patients with acute pancreatitis.

Ischaemic colitis commonly affects the splenic flexure, which is a watershed area for arterial supply from the superior and inferior mesenteric artery. The descending colon is supplied by the left colic branch of the inferior mesenteric artery, while the hepatic flexure is supplied by the right colic branch of the superior mesenteric artery. The rectum receives arterial blood from the inferior mesenteric artery, middle rectal artery (from internal iliac artery), and inferior rectal artery (from the internal pudendal artery). The sigmoid colon is the second most common site for ischaemic colitis and is also a watershed area known as ‘Sudeck’s point’.

Understanding Ischaemic Colitis

Ischaemic colitis is a condition that occurs when there is a temporary reduction in blood flow to the large bowel. This can cause inflammation, ulcers, and bleeding. The condition is more likely to occur in areas of the bowel that are located at the borders of the territory supplied by the superior and inferior mesenteric arteries, such as the splenic flexure.

When investigating ischaemic colitis, doctors may look for a sign called thumbprinting on an abdominal x-ray. This occurs due to mucosal edema and hemorrhage. It is important to diagnose and treat ischaemic colitis promptly to prevent complications and ensure a full recovery.

During a coronary artery bypass graft (CABG), the great saphenous vein is often harvested. However, this procedure can lead to damage of the saphenous nerve, which runs closely alongside the vein in the medial aspect of the leg. Saphenous neuralgia, characterized by numbness, heightened sensitivity, and pain in the saphenous nerve distribution area, can result from such injury. Other nerves are not typically affected during a vein harvest for CABG.

During surgical procedures, there is a risk of nerve injury caused by the surgery itself. This is not only important for the patient’s well-being but also from a legal perspective. There are various operations that carry the risk of nerve damage, such as posterior triangle lymph node biopsy, Lloyd Davies stirrups, thyroidectomy, anterior resection of rectum, axillary node clearance, inguinal hernia surgery, varicose vein surgery, posterior approach to the hip, and carotid endarterectomy. Surgeons must have a good understanding of the anatomy of the area they are operating on to minimize the incidence of nerve lesions. Blind placement of haemostats is not recommended as it can also cause nerve damage.

Barrett’s oesophagus is characterized by the replacement of the original stratified squamous epithelium with columnar epithelium, which is typically found lining the intestines. Simple cuboidal epithelium is present in small gland ducts, kidney tubules, and secretory portions. Pseudostratified columnar epithelium is found in the upper respiratory tract and trachea, while stratified squamous epithelium lines areas that experience tension, such as the mouth, oesophagus, and vagina.

Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, which increases the risk of oesophageal adenocarcinoma by 50-100 fold. It is usually identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia, as there are no screening programs for it. The length of the affected segment determines the chances of identifying metaplasia, with short (<3 cm) and long (>3 cm) subtypes. The prevalence of Barrett’s oesophagus is estimated to be around 1 in 20, and it is identified in up to 12% of those undergoing endoscopy for reflux.

The columnar epithelium in Barrett’s oesophagus may resemble that of the cardiac region of the stomach or that of the small intestine, with goblet cells and brush border. The single strongest risk factor for Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD), followed by male gender, smoking, and central obesity. Alcohol is not an independent risk factor for Barrett’s, but it is associated with both GORD and oesophageal cancer. Patients with Barrett’s oesophagus often have coexistent GORD symptoms.

The management of Barrett’s oesophagus involves high-dose proton pump inhibitor, although the evidence base for its effectiveness in reducing the progression to dysplasia or inducing regression of the lesion is limited. Endoscopic surveillance with biopsies is recommended every 3-5 years for patients with metaplasia but not dysplasia. If dysplasia of any grade is identified, endoscopic intervention is offered, such as radiofrequency ablation, which is the preferred first-line treatment, particularly for low-grade dysplasia, or endoscopic mucosal resection.

The secretion of gastrin hormone from G cells in the antrum of the stomach is responsible for increasing the secretion of H+ by gastric parietal cells. Additionally, chief cells secrete pepsin, which is a proteolytic enzyme, while D cells in the pancreas and stomach secrete somatostatin hormone. Gastrin hormone is released in response to distension of the stomach and vagal stimulation.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

Gastrointestinal stromal tumors (GISTs) originate from Cajal’s interstitial pacemaker cells, which are typically found outside the mucosal layer and cause minimal damage to it.

Gastrointestinal Stromal Tumours: Characteristics and Treatment Options

Gastrointestinal stromal tumours (GISTs) are rare tumours that originate from the interstitial pacemaker cells of Cajal. These tumours are primarily found in the stomach (70%), with the remainder occurring in the small intestine (20%) and colon/rectum (5%). Most GISTs are solitary lesions and are sporadic in nature. The majority of GISTs express CD117, a transmembrane tyrosine kinase receptor, and have a mutation of the c-KIT gene.

The main goal of surgery for GISTs is to resect the tumour with a 1-2 cm margin of normal tissue. Extensive resections are not usually required. However, there is a high local recurrence rate, which is related to the site of the tumour, incomplete resections, and high mitotic count. Salvage surgery for recurrent disease is associated with a median survival of 15 months.

In high-risk patients, the use of imatinib has greatly improved prognosis. In the ACOSOG trial, imatinib reduced relapse rates from 17% to 2%. In the UK, imatinib is recommended by NICE for use in patients with metastatic disease or locally unresectable disease.

Overall, GISTs are rare tumours that require careful management. Surgery with a margin of normal tissue is the mainstay of treatment, but the risk of recurrence is high. Imatinib has shown promise in improving prognosis for high-risk patients.

Amylase is an enzyme that converts starch into sugars.

Enzymes play a crucial role in the breakdown of carbohydrates in the gastrointestinal system. Amylase, which is present in both saliva and pancreatic secretions, is responsible for breaking down starch into sugar. On the other hand, brush border enzymes such as maltase, sucrase, and lactase are involved in the breakdown of specific disaccharides. Maltase cleaves maltose into glucose and glucose, sucrase cleaves sucrose into fructose and glucose, while lactase cleaves lactose into glucose and galactose. These enzymes work together to ensure that carbohydrates are broken down into their simplest form for absorption into the bloodstream.

Budd-Chiari syndrome, which is characterized by abdominal pain, ascites, hepatomegaly, and jaundice, can be caused by hypercoagulable states such as protein C and S deficiencies. In this case, the patient’s protein C deficiency increased their risk of developing a thrombus in the hepatic veins, leading to Budd-Chiari syndrome. Other risk factors for thrombus formation include pregnancy and hepatocellular carcinoma. The use of oral contraceptives would also increase the risk of thrombus formation, while warfarin treatment would decrease it. Atrial fibrillation, on the other hand, would predispose a patient to systemic embolism, which can cause ischaemic symptoms in various arterial circulations.

Understanding Budd-Chiari Syndrome

Budd-Chiari syndrome, also known as hepatic vein thrombosis, is a condition that is often associated with an underlying hematological disease or another procoagulant condition. The causes of this syndrome include polycythemia rubra vera, thrombophilia, pregnancy, and the use of combined oral contraceptive pills. The symptoms of Budd-Chiari syndrome typically include sudden onset and severe abdominal pain, ascites leading to abdominal distension, and tender hepatomegaly.

To diagnose Budd-Chiari syndrome, an ultrasound with Doppler flow studies is usually the initial radiological investigation. This test is highly sensitive and can help identify the presence of the condition. It is important to diagnose and treat Budd-Chiari syndrome promptly to prevent complications such as liver failure and portal hypertension.